Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Single-Center Experience with 15 VitalFlow ECMO Deployments for VA- and VV-ECMO Support: Deployment Characteristics, Outcomes, and Complications.

Journal of cardiovascular development and disease·2026
Same author

Impact of Virtual Reality on Transcatheter Aortic Valve Implantation: A Prospective Randomized Controlled Trial.

Circulation. Cardiovascular imaging·2026
Same author

Heart Transplantation on Temporary Mechanical Circulatory Support: A Single-Center Study (2010-2024).

The Thoracic and cardiovascular surgeon·2026
Same author

Valve-Sparing Versus Composite Graft Aortic Root Replacement in Acute Type A Aortic Dissection with Standardized Hemiarch Repair: A Propensity Score Matching Analysis.

Journal of cardiovascular development and disease·2026
Same author

Predictive Value of MELD Score and Charlson Comorbidity Index in Thoracic Aortic Surgery Patients.

Journal of cardiovascular development and disease·2025
Same author

"End-of-Life Care" in Cardiac Surgery.

The Thoracic and cardiovascular surgeon·2025

相关实验视频

Updated: Jul 22, 2025

Transplantation of a 3D Bioprinted Patch in a Murine Model of Myocardial Infarction
07:47

Transplantation of a 3D Bioprinted Patch in a Murine Model of Myocardial Infarction

Published on: September 26, 2020

6.6K

使用新的双补丁技术进行左心室辅助装置的探索†

Oliver Daniel Bhadra1, Jonas Pausch1, Hug Aubin2

  • 1University Heart & Vascular Center Hamburg, Department for Cardiovascular Surgery, Hamburg, Germany.

Interdisciplinary cardiovascular and thoracic surgery
|July 24, 2023
PubMed
概括
此摘要是机器生成的。

左心室辅助装置 (LVAD) 的探索是可行的,并使用新的双补丁技术安全. 这种方法确保了100%的生存率和没有并发症,允许停止抗凝药治疗.

关键词:
心脏衰竭是因为心脏衰竭.左心室辅助装置 探测 探测左心室辅助装置 断奶 断奶机械循环支持 机械循环支持

更多相关视频

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.1K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K

相关实验视频

Last Updated: Jul 22, 2025

Transplantation of a 3D Bioprinted Patch in a Murine Model of Myocardial Infarction
07:47

Transplantation of a 3D Bioprinted Patch in a Murine Model of Myocardial Infarction

Published on: September 26, 2020

6.6K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.1K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K

科学领域:

  • 心脏病学 心脏病学
  • 心血管外科心血管外科
  • 医疗器械 医疗器械

背景情况:

  • 在心脏恢复后,用于左心室辅助器件 (LVAD) 探索的手术选择各不相同.
  • 剩余的LVAD成分存在感染和血栓形成的风险.
  • 介绍了一种用于LVAD扩张的新双贴技术.

研究的目的:

  • 报告一项用于LVAD扩张的新型双贴片技术.
  • 为了评估这项技术的安全性和可行性在两个中心的经验中.
  • 评估包括生存和并发症在内的结果.

主要方法:

  • 在2019年3月至2021年4月期间,五名患者接受了LVAD扩张 (HVAD:2;HeartMate:3:3).
  • 这项手术涉及中间椎切除,心肺旁路,以及顶部的双补丁关闭 (心周和高尔-德克斯).
  • 患者平均年龄为50.3岁;使用LVAD的平均时间为23.1个月.

主要成果:

  • 所有五个LVAD解释都在技术上没有任何复杂性.
  • 在平均随访时间为16.4个月期间,观察到100%的存活率.
  • 没有出现出血并发症或血栓塞栓事件.

结论:

  • 使用双补丁技术的LVAD扩张是可行的和安全的.
  • 这种技术允许停止抗凝血治疗.
  • 实现了100%的30天存活率,这证明了进一步的长期随访研究的必要性.